Discontinued — last reported Q4 '25
UnitedHealth Group Business Sale Proceeds remained flat by 0.0% to $510.25M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 198.0%, from $171.25M to $510.25M. Over 3 years (FY 2021 to FY 2024), Business Sale Proceeds shows an upward trend with a 414.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Inflows represent capital recycling or strategic pruning of the portfolio.
Cash inflows resulting from the divestiture of business units, subsidiaries, or assets. This metric highlights the compa...
Standard investing activity metric for companies undergoing restructuring or portfolio optimization.
cf_proceeds_from_sale_of_business| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $15.00M | $3.41B | $685.00M | $2.04B |
| YoY Change | — | >999% | -79.9% | +198.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.